|
|
Hepatitis C Medications
Approved Medications
- ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- An Overview of Peginterferon Alfa-2 (Pegasys, PEG-Intron) (January 10, 2005)
To read PDF, click here
From U.S. National Institutes of Health
- An Overview of Interferon Alfa-2 (Roferon-A, Intron A) (January 4, 2005)
To read PDF, click here
From U.S. National Institutes of Health
- New Hepatitis C Treatment Options Available (September 20, 2004)
Updates on generic ribavirin and the approval of two forms of peg-interferon.
To read PDF, click here
From PositiveWords
- Focus on Hepatitis: Final APRICOT, ACTG A5071 Results (September 2004)
Data indicate that sustained virologic response can be achieved with peginterferon-alfa and ribavirin in many HIV/hepatitis C-coinfected patients.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Hepatitis C and Complementary and Alternative Medicine: 2003 Update (May 2004)
To read PDF, click here
From U.S. National Center for Complementary and Alternative Medicine
- An Overview of Ribavirin (Virazol, Rebetol, Copegus) (March 4, 2004)
To read PDF, click here
From U.S. National Institutes of Health
- HCV Treatment and Monitoring Guide (August 2003)
A basic guide to hepatitis C medications.
To read PDF, click here
In WISE Words, from Project Inform
- The Management of Adverse Effects with PEG-Interferon/Ribavirin Combination Therapy is a Significant Challenge (March 2003)
To read PDF, click here
From HCV Advocate
- FDA Approves Pegasys for Hepatitis C (October 17, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Study: Hepatitis Shots Show Promise (September 26, 2002)
In a recent study, peginterferon alfa-2a plus ribavirin beats the standard hepatitis C treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Why Interferon Induction Therapy Has Been a Failure (April 2002)
To read PDF, click here
From HCV Advocate
- Important Drug Warning: Intron A (PDF) (December 2001)
From U.S. Food and Drug Administration
- Novel Treatments for HCV (October 21, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
- Hepatitis C: Progress Beyond Interferon (October 19, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
- FDA Approves Peg-Interferon and Ribavirin Treatment Combination (September 21, 2001)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Important Drug Warning: Roferon-A (PDF) (September 2001)
From U.S. Food and Drug Administration
- FDA Approves Stand-Alone Package of Rebetol (Ribavirin) for Combination Therapy With Intron A for the Treatment of Chronic Hepatitis C Infection (July 26, 2001)
See also Rebetol (Ribavirin) Product Information (2001) (PDF).
From U.S. Food and Drug Administration
- Revised Package Insert: Roferon-A (Interferon Alfa-2a, Recombinant) (PDF) (March 20, 2001)
From U.S. Food and Drug Administration
- Peg-Interferon-Alfa Approved for Hepatitis C (March 2001)
In What's New, from Project Inform
- Revised Package Insert: Intron A (Interferon Alfa-2b, Recombinant for Injection) (PDF) (February 2001)
From U.S. Food and Drug Administration
- New Drugs in Development: Pegylated Interferons for the Treatment of Hepatitis C (Summer 2000)
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America
- Evolving Strategies to Attack Hepatitis C (December 1998)
New treatment combinations are highly toxic but have substantial success rates.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Hepatitis C: New Treatment Overview (September 4, 1998)
From AIDS Treatment News
- Can Science Meet the Challenges of the HCV Pandemic? (July 1998)
New treatment options for chronic Hepatitis C.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Ribavirin Approved for Hepatitis C Combination Treatment (June 22, 1998)
From AIDS Treatment News
- Hepatitis C -- Important Treatment Advance (May 15, 1998)
An interview with Douglas Dieterich, M.D.
In AIDS Treatment News, from AIDS Treatment News
- Hepatitis C and HIV: Ribavirin Plus Interferon Study Recruiting (May 15, 1998)
In AIDS Treatment News, from AIDS Treatment News
- Alright Thymosin! (April 1996)
In Notes From the Underground, from PWA Health Group
New or Experimental Medications
- Hepatitis C: New Treatments in the Pipeline (April 2008)
To read PDF, click here
From Treatment Action Group
- Is a New Generation of HCV Treatment Near? (November 2, 2007)
In The New York Times
- What’s in the Hep C Pipeline? (Fall 2007)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
- Studying New Drugs for HCV (September 2007)
Excerpts from the FDA hearings.
To read PDF, click here
In TAGline, from Treatment Action Group
- The Sitges Statement on HCV Drug Development (September 2007)
To read PDF, click here
In TAGline, from Treatment Action Group
- Research Into New Drugs to Treat HCV (August 2007)
To read PDF, click here
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group
- Hepatitis C at CROI: Growing Chasm Between Bench and Bedside (April 2006)
A brief review of research on experimental treatments presented at the 13th Conference on Retroviruses and Opportunistic Infections.
To read PDF, click here
In TAGline, from Treatment Action Group
- The Hepatitis C Treatment Pipeline (Spring 2006)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
- Future Therapies (February 2006)
To read PDF, click here
From HCV Advocate
- FDA Approves Hepatitis C Treatment Ribasphere (December 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Vertex's Hepatitis C Drug VX-950 Gets FDA Fast Track (December 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Hepatitis C Virus Treatment Pipeline (September 29, 2005)
To read PDF, click here
In TAGline, from Treatment Action Group
- Protease Inhibitors for Hepatitis C Treatment: Glimpses of Hope on a Distant Horizon (August 2004)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Attacking the Hepatitis C Virus with New Mechanisms of Action: Drugs in the Pipeline (May 2004)
To read PDF, click here
From HCV Advocate
- Proliferation of Polymerase Inhibitors and Other Tales From the HCV Crypt (February 2004)
A look at the various drugs in the hepatitis C treatment pipeline.
In TAGline, from Treatment Action Group
- Hepatitis C Treatment May Halve Injections (November 6, 2002)
Albuferon-alpha may be easier treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Future Of Western Treatment For Hepatitis C (March 2002)
To read PDF, click here
From HCV Advocate
- Future HCV Therapies (January 2002)
To read PDF, click here
From HCV Advocate
- Novel Treatments for HCV (October 21, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
Drug Pricing
|
|
